article thumbnail

Important factors to consider when working with CRFs

pharmaphorum

They must also comply with regulatory requirements, such as those defined by the FDA. Well-designed forms must: Gather data that’s complete, accurate, and of high quality. Well-designed forms must: Gather data that’s complete, accurate, and of high quality. Be unambiguous and allow for accurate data entry.

article thumbnail

Important factors to consider when working with CRFs

pharmaphorum

They must also comply with regulatory requirements, such as those defined by the FDA. Well-designed forms must: Gather data that’s complete, accurate, and of high quality. Well-designed forms must: Gather data that’s complete, accurate, and of high quality. Be unambiguous and allow for accurate data entry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies

pharmaphorum

Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. Increased study adherence: Patients are most familiar with their own devices, and the ability to download an application and complete entries on a device they understand increases their adherence to the study requirements.

article thumbnail

Intelligent Automation in Pharmaceutical Industry (AI & ML)

PharmaShots

Regulatory Compliance: Companies must emphasize the guidelines set by the regulatory body, be it FDA or EMA, to ensure good manufacturing practices. In such cases, companies may initially begin by infusing small aspects of Robotic Process Automation (RPA) into essential areas like R&D, clinical trials, and patient data entry.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Ensuring data integrity in the life science industry is crucial for regulatory compliance. Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry.

article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has provided guidance for the use of RFID in the drug supply chain and to standardise the data format. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.

Labelling 105
article thumbnail

Paperless Validation Systems: Truly Paperless?

ISPE

Without being 100% assured that a system can prevent incorrect data and lacking trust in a single person entering or creating data, the result tends to be overengineered processes and manual checkpoints with physical extractions. So, we added another pair of eyes to ensure the data entry is accurate.